Home Therapeutic Areas Cardio-Metabolic
Home Therapeutic Areas Cardio-Metabolic
Product information is intended for healthcare professionals. Please refer to the approved prescribing information for full details of indications, dosage and safety.
Rivaroxaban
10 mg · 15 mg · 20 mg
About Vixvert®
Indication: Prevention and treatment of venous thromboembolic disorders, including DVT and pulmonary embolism (PE), and prevention of VTE following hip or knee replacement surgery.
Strengths: 10 mg, 15 mg, 20 mg
Dosage Form: Film-Coated Tablets
Active Ingredient: Rivaroxaban
Ticagrelor
90 mg
About Ticagrelor SPC®
Indication: Used in combination with acetylsalicylic acid (ASA) to reduce the risk of cardiovascular events in adults with acute coronary syndrome (ACS), including heart attack or unstable angina.
Strength: 90 mg
Dosage Form: Film-Coated Tablets
Active Ingredient: Ticagrelor
Apixaban
2.5 mg · 5 mg
About Pixar®
Pixar® (Apixaban Film-Coated Tablets)
Indication: Prevention and treatment of thromboembolic disorders, including DVT, pulmonary embolism (PE), and stroke prevention in patients with non-valvular atrial fibrillation (NVAF).
Strengths: 2.5 mg, 5 mg
Dosage Form: Film-Coated Tablets
Active Ingredient: Apixaban
Sacubitril/Valsartan
50 mg · 100 mg · 200 mg
About Saventi®
Indication: Treatment of chronic heart failure in adults to improve cardiovascular outcomes.
Strengths: 50 mg, 100 mg, 200 mg
Dosage Form: Film-Coated Tablets
Active Ingredient: Sacubitril/Valsartan
Empagliflozin
10 mg · 25 mg
About Monzeva®
Indication: Treatment of type 2 diabetes mellitus in adults, as monotherapy or in combination with other antidiabetic medications.
Strengths: 10 mg, 25 mg
Dosage Form: Film-Coated Tablets
Active Ingredient: Empagliflozin
Sitagliptin
25 mg · 50 mg · 100 mg
About Juleen®
Indication: Treatment of type 2 diabetes mellitus in adults to improve glycemic control, as monotherapy or in combination with other antidiabetic medications.
Strengths: 25 mg, 50 mg, 100 mg
Dosage Form: Film-Coated Tablets
Active Ingredient: Sitagliptin
Dapagliflozin
5 mg · 10 mg
About Daglozin®
Indication: Treatment of type 2 diabetes mellitus in adults and children ≥10 years, as monotherapy or in combination with other antidiabetic medications.
Strengths: 5 mg, 10 mg
Dosage Form: Film-Coated Tablets
Active Ingredient: Dapagliflozin
